David Scadden - 01 Jul 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CARM	Stock Option (Right to Buy)	Award	$0	+38,700		$0.000000	38,700	01 Jul 2024	Common Stock	38,700	$1.67	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying this option vest over three years in equal monthly installments following July 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.